{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:13:03Z","timestamp":1789135983993,"version":"build-2803163510"},"reference-count":41,"publisher":"Scientific Scholar","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jor.2025.05.018","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:21:06Z","timestamp":1746724866000},"page":"227-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["GLP-1 receptor agonist use in elective lumbar spine surgery: Reduced pseudarthrosis rates and favorable safety profile"],"prefix":"10.25259","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8090-4575","authenticated-orcid":false,"given":"Sri","family":"Tummala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7150-8555","authenticated-orcid":false,"given":"David C.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-4718","authenticated-orcid":false,"given":"Joseph","family":"Chavarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Avramis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Rizkalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"10.1016\/j.jor.2025.05.018_bib1","article-title":"The use of semaglutide in patients undergoing lumbar fusion does not increase 90-day medical or 1-year mechanical complications","volume":"17","author":"Ghali","year":"2025","journal-title":"Clin Spine Surg"},{"key":"10.1016\/j.jor.2025.05.018_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eprac.2023.11.007","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists on body weight and cardiometabolic parameters in individuals with obesity and without diabetes: a systematic review and meta-analysis","volume":"30","author":"Ansari","year":"2024","journal-title":"Endocr Pract"},{"issue":"10","key":"10.1016\/j.jor.2025.05.018_bib3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.spinee.2016.06.005","article-title":"Outcomes and revision rates in normal, overweight, and obese patients 5 years after lumbar fusion","volume":"16","author":"Owens","year":"2016","journal-title":"Spine J"},{"issue":"2","key":"10.1016\/j.jor.2025.05.018_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12178-022-09814-y","article-title":"The effect of diabetes and metabolic syndrome on spine surgery outcomes","volume":"16","author":"Bajaj","year":"2023","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"3","key":"10.1016\/j.jor.2025.05.018_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3171\/2010.11.SPINE10139","article-title":"Economic impact of comorbidities in spine surgery: clinical article","volume":"14","author":"Walid","year":"2011","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"10.1016\/j.jor.2025.05.018_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/BRS.0b013e318273583a","article-title":"Characteristics of diabetes associated with poor improvements in clinical outcomes after lumbar spine surgery","volume":"38","author":"Takahashi","year":"2013","journal-title":"Spine"},{"issue":"3","key":"10.1016\/j.jor.2025.05.018_bib7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s11999-013-3346-3","article-title":"Does obesity affect the surgical outcome and complication rates of spinal surgery? A meta-analysis","volume":"472","author":"Jiang","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jor.2025.05.018_bib8","article-title":"Diabetes management in spinal surgery journal of clinical images and medical case reports introduction and significance","volume":"3","author":"Lucke-Wold","year":"2022","journal-title":"Open Access"},{"issue":"12","key":"10.1016\/j.jor.2025.05.018_bib9","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s00701-018-3722-6","article-title":"Prior bariatric surgery lowers complication rates following spine surgery in obese patients","volume":"160","author":"Passias","year":"2018","journal-title":"Acta Neurochir"},{"issue":"24","key":"10.1016\/j.jor.2025.05.018_bib10","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.2106\/JBJS.N.00064","article-title":"Risk factors for poor outcome of cervical laminoplasty for cervical spondylotic myelopathy in patients with diabetes","volume":"96","author":"Machino","year":"2014","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"10.1016\/j.jor.2025.05.018_bib11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.spinee.2022.02.014","article-title":"Optimal hemoglobin A1C target in diabetics undergoing elective cervical spine surgery","volume":"22","author":"Roth","year":"2022","journal-title":"Spine J"},{"issue":"19","key":"10.1016\/j.jor.2025.05.018_bib12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/BRS.0000000000000482","article-title":"Outcomes and complications of diabetes mellitus on patients undergoing degenerative lumbar spine surgery","volume":"39","author":"Guzman","year":"2014","journal-title":"Spine"},{"issue":"6","key":"10.1016\/j.jor.2025.05.018_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.0416","article-title":"Association between preoperative metformin exposure and postoperative outcomes in adults with type 2 diabetes","volume":"155","author":"Reitz","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jor.2025.05.018_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2015.04.026","article-title":"Effects of diabetes drugs on the skeleton","volume":"82","author":"Meier","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.jor.2025.05.018_bib15","article-title":"FDA approves new drug treatment for chronic weight management, first since 2014","volume":"21","year":"2021","journal-title":"FDA. June"},{"issue":"2","key":"10.1016\/j.jor.2025.05.018_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/medicina58020224","article-title":"The impact of GLP1 agonists on bone metabolism: a systematic review","volume":"58","author":"Daniilopoulou","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jor.2025.05.018_bib17","article-title":"GLP\u22121 receptor agonists for the treatment of obesity: role as a promising approach","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.jor.2025.05.018_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16775","article-title":"Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial","volume":"7","author":"Jensen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jor.2025.05.018_bib19","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jor.2025.05.018_bib20","article-title":"Poll: roughly 12% of US adults have used a GLP-1 drug, even if unaffordable","volume":"332","author":"Harris","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jor.2025.05.018_bib21","series-title":"Diabetes in America","article-title":"Prevalence and incidence of type 2 diabetes and prediabetes","author":"Cowie","year":"2018"},{"key":"10.1016\/j.jor.2025.05.018_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065425","article-title":"Trends in body mass index, overweight and obesity among adults in the USA, the NHANES from 2003 to 2018: a repeat cross-sectional survey","volume":"12","author":"Li","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jor.2025.05.018_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18417-z","article-title":"Analysis of risk factors for perioperative complications in spine surgery","volume":"12","author":"Lange","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jor.2025.05.018_bib24","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.spinee.2017.03.019","article-title":"Complications and readmission after lumbar spine surgery in elderly patients: an analysis of 2,320 patients","volume":"17","author":"Saleh","year":"2017","journal-title":"Spine J"},{"key":"10.1016\/j.jor.2025.05.018_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bpa.2016.01.002","article-title":"Postoperative complications of spine surgery","volume":"30","author":"Swann","year":"2016","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.jor.2025.05.018_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jama.1992.03490070089049","article-title":"Patient outcomes after lumbar spinal fusions","volume":"268","author":"Turner","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jor.2025.05.018_bib27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.arth.2023.12.023","article-title":"Semaglutide use prior to total hip arthroplasty results in fewer postoperative prosthetic joint infections and readmissions","volume":"39","author":"Magruder","year":"2024","journal-title":"J Arthroplast"},{"key":"10.1016\/j.jor.2025.05.018_bib28","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthropl"},{"key":"10.1016\/j.jor.2025.05.018_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/BSD.0000000000001775","article-title":"Fusion outcomes of GLP-1 agonist therapy in multilevel cervical spinal fusion: a propensity-matched analysis","author":"Vatsia","year":"2025","journal-title":"Clin Spine Surg"},{"key":"10.1016\/j.jor.2025.05.018_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fendo.2017.00098","article-title":"The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms","volume":"8","author":"Zhao","year":"2017","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1016\/j.jor.2025.05.018_bib31","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jbmr.1898","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats","volume":"28","author":"Ma","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.jor.2025.05.018_bib32","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2015-1176","article-title":"GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women","volume":"100","author":"Iepsen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jor.2025.05.018_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes \u2013 a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jor.2025.05.018_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-014-0361-4","article-title":"Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials","volume":"48","author":"Su","year":"2015","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.jor.2025.05.018_bib35","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/1753-0407.12102","article-title":"Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials","volume":"6","author":"Mabilleau","year":"2014","journal-title":"J Diabetes"},{"key":"10.1016\/j.jor.2025.05.018_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jor.2025.05.018_bib37","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00586-018-5513-4","article-title":"Epidemiological trends in spine surgery over 10 years in a multicenter database","volume":"27","author":"Kobayashi","year":"2018","journal-title":"Eur Spine J"},{"key":"10.1016\/j.jor.2025.05.018_bib38","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2106\/JBJS.17.01316","article-title":"Postoperative blood glucose levels predict infection after total joint arthroplasty","volume":"100","author":"Kheir","year":"2018","journal-title":"J Bone Joint Surg Am."},{"key":"10.1016\/j.jor.2025.05.018_bib39","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2147\/TCRM.S185221","article-title":"The effect of diabetes on perioperative complications following spinal surgery: a metaanalysis","volume":"14","author":"Luo","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jor.2025.05.018_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae053","article-title":"Diabetes increases risk of lumbar spinal fusion complications: association with altered structure of newly formed bone at the fusion site","volume":"8","author":"Wilson","year":"2024","journal-title":"JBMR Plus"},{"key":"10.1016\/j.jor.2025.05.018_bib41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/a-1844-1176","article-title":"The antiobesity effect and safety of GLP-1 receptor agonist in overweight\/obese patients without diabetes: a systematic review and meta-analysis","volume":"54","author":"Guo","year":"2022","journal-title":"Horm Metab Res"}],"container-title":["Journal of Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X25001643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X25001643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:03:15Z","timestamp":1789135395000},"score":1,"resource":{"primary":{"URL":"https:\/\/jortho.org\/glp-1-receptor-agonist-use-in-elective-lumbar-spine-surgery-reduced-pseudarthrosis-rates-and-favorable-safety-profile\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"alternative-id":["S0972978X25001643"],"URL":"https:\/\/doi.org\/10.1016\/j.jor.2025.05.018","relation":{},"ISSN":["0972-978X"],"issn-type":[{"value":"0972-978X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonist use in elective lumbar spine surgery: Reduced pseudarthrosis rates and favorable safety profile","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jor.2025.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}